Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
Confidence of US consumers continues to decline as Americans worry about the future
WASHINGTON (AP) — U.S. consumer confidence deteriorated for the third straight month as Americans co2024-05-01China's cargo, container throughput rises in first two months
Aerial photo taken on Jan. 26, 2022 shows cargo ships docking at the Rizhao Port in Rizhao, east Chi2024-05-01Public satisfaction increases on Chinse delivery rates
The public are becoming more satisfied with China's parcel delivery service last year, and meanwhile2024-05-01Alibaba returns to simple and agile structure
Jack Ma, co-founder of Chinese tech heavyweight Alibaba Group Holding Ltd, affirmed on Wednesday the2024-05-01King Charles marks return to public duties wearing his famed pink T
King Charles today marked his return to public duties wearing his famed pink and blue T-rex tie.His2024-05-01Xinhua Headlines: Shanghai boosts supply of necessities amid COVID
* Shanghai's 25 million residents have been living under closed-off management since late March due2024-05-01
atest comment